Publication details
Dopad genetických aberací na terapie zahrnující Rituximab v 1. linii léčby pacientů s CLL
| Authors | |
|---|---|
| Year of publication | 2017 |
| Type | Requested lectures |
| MU Faculty or unit | |
| Citation |
| Authors | |
|---|---|
| Year of publication | 2017 |
| Type | Requested lectures |
| MU Faculty or unit | |
| Citation |